Know what your health looks like when you feel well
150+ lab tests across two draws, explained in plain language
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
The symptoms COVID-19 most often causes
COVID-19 is the illness caused by the SARS-CoV-2 coronavirus. COVID symptoms most often include fever, cough, sore throat, and fatigue, plus body aches and changes to smell or taste.
SARS-CoV-2 symptoms group by body system:
- Flu-like: fever or chills, fatigue, body aches, and headache
- Respiratory: cough, sore throat, congestion or a runny nose, and shortness of breath
- Sensory: changes to or loss of smell and taste
- Digestive: nausea, vomiting, and diarrhea
No symptom list confirms an infection. An estimated 35.1% of infections never cause symptoms, and someone who feels well can still spread the virus.
When COVID symptoms start, and what shows up first
COVID-19 symptoms usually begin about 5 days after exposure, and they can appear anywhere from 2-14 days later. Pooled across 142 studies, the incubation period averaged 6.57 days. Feeling fine on day two tells you very little about day six.
The virus has also sped up. Incubation shortened with each dominant variant, from 5 days with Alpha to 4.41 with Delta and 3.42 days with Omicron.
There is no fixed order of arrival. During Omicron, community testing found cough in 67.4% of symptomatic people who tested positive, and sore throat in 43.4%.
When COVID symptoms are an emergency
A short list of symptoms needs emergency help straight away, not a call to a regular clinician.
- Sudden chest pain or pressure
- Breathlessness so severe you cannot say short sentences at rest
- Coughing up blood
- Collapse, fainting, or a first seizure
- A rash that does not fade when a glass is pressed on it
- New confusion
- Skin, lips, or nail beds that turn blue or gray
One tier down, same-day advice is warranted when symptoms keep worsening, or a high temperature lasts 5 days or more.
COVID vs. flu vs. cold: how the symptoms differ
These three illnesses overlap so heavily that pattern matters more than any single symptom. Testing is the only way to be certain which one you have.
| Symptom | COVID-19 | Flu | Cold |
|---|---|---|---|
| Onset after exposure | About 5 days, up to 14 | 1 to 4 days | Varies |
| Fever | 74% | 68% | 40% |
| Sore throat | Common | Common | Common |
| Body aches | 29% | 94% | 94% |
| Runny or stuffy nose | 4% | 91% | 81% |
| Changes to smell or taste | A telling sign of COVID-19 | Not a distinguishing feature | Not a distinguishing feature |
Those figures predate Omicron, so they are directional rather than current. Sore throat in particular became markedly more common with Omicron, which is why no single number captures it.
How long COVID symptoms last
Among people recovering at home, median symptom duration was 9 days, measured in outpatients, not hospitalized patients.
Duration splits by symptom. Congestion, sore throat, and cough usually settle within about 2 weeks, while tiredness and shortness of breath can linger for weeks or months.
Illness during the Omicron period ran shorter too, with less lower-respiratory-tract involvement than during Delta.
How newer variants changed the symptom mix
Variants are successive versions of the same virus, and each one that takes over shifts which symptoms show up.
Between the Delta period of late 2021 and the Omicron period in early 2022, loss of smell fell from 52.7% to 16.7%. Sore throat moved the other way, rising from 60.8% to 70.5%.
That shift comes with a cost. The symptoms that once flagged COVID-19 are less distinctive now, so symptom patterns alone detect it less reliably than before.
How COVID symptoms differ in children
Children catch the same virus and present differently often enough that adult expectations mislead. Through the Omicron period, symptoms ran more common in adults than in children.
- Roughly 46.7% of infections in children never produce symptoms, against 19.7% in older adults.
- Symptoms start later, with a pooled incubation of 8.82 days in children.
- When children do get sick, fever and cough track with recent variants, in a cohort recruited at pediatric emergency departments.
Who is more likely to get severely ill
Risk factors compound rather than act alone, so identical symptoms carry different weight depending on who has them. Before vaccination was widespread, COVID-19-related death rose steeply with age and was higher in men. Diabetes and severe asthma were among the conditions associated with further risk. Those are relative risk patterns from that era, not your odds today.
Current guidance considers people aged 60 or over, people who are pregnant, and people with a weakened immune system to be at higher risk.
Get 150+ lab tests from home
Two blood draws a year. A full picture of your health, explained in plain language.
Get 150+ lab tests from home
Two blood draws a year. A full picture of your health, explained in plain language.
What to do if you have COVID symptoms
Between noticing symptoms and needing emergency care sits a short, practical sequence.
- Test, since overlapping symptoms cannot tell you which illness you have, and rapid antigen tests can stay positive past the first days.
- Stay away from others, since you are contagious from a couple of days before symptoms until roughly 8-10 days after.
- Rest and drink plenty of fluids.
- Ask a clinician promptly about antiviral medication if you are in a higher-risk group, since benefit was measured when it started within 3 days of symptoms.
- Watch for the emergency signs, and call emergency services if any appear.
When symptoms last for months: long COVID
When symptoms persist well past the acute infection, that is long COVID. Pooled estimates put its prevalence at about 36% of infections. Severity changes the picture, with 34% among people not hospitalized against 54% among those who were. Estimates swing widely with the population and definition used.
The most common clusters are respiratory symptoms and general fatigue, each around 20%, followed by psychological and neurological symptoms. Being unvaccinated, catching a pre-Omicron variant, and female sex were the strongest associated risk factors.
Know your baseline with Superpower
COVID symptoms are easiest to read against a picture of your biology taken while you feel well. A Superpower membership includes two blood draws, an initial baseline and a partial re-draw of your most critical markers, for 150+ lab tests. Results sit in one place, tracked between draws, with a personalized plan for the markers you want to move.
Knowing your own numbers is the difference between reacting to how you feel and understanding it. Start your Superpower membership and get your baseline in one draw.
Frequently Asked Questions
References
- Cleveland Clinic (2025). Coronavirus disease (COVID-19): symptoms and treatment. *Cleveland Clinic Health Library*.
- Sah P, Fitzpatrick MC, Zimmer CF, Abdollahi E, Juden-Kelly L, Moghadas SM, Singer BH, Galvani AP (2021). Asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis. *Proceedings of the National Academy of Sciences*, *118*(34), e2109229118. https://doi.org/10.1073/pnas.2109229118
- National Institutes of Health (2022). Is it flu, COVID-19, allergies, or a cold? *NIH News in Health*, January 2022.
- Wu Y, Kang L, Guo Z, Liu J, Liu M, Liang W (2022). Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis. *JAMA Network Open*, *5*(8), e2228008. https://doi.org/10.1001/jamanetworkopen.2022.28008
- Marquez C, Kerkhoff AD, Schrom J, Rojas S, Black D, Mitchell A, et al. (2022). COVID-19 symptoms and duration of rapid antigen test positivity at a community testing and surveillance site during pre-Delta, Delta, and Omicron BA.1 periods. *JAMA Network Open*, *5*(10), e2235844. https://doi.org/10.1001/jamanetworkopen.2022.35844
- NHS (2023). COVID-19 symptoms and what to do. *National Health Service*.
- Czubak J, Stolarczyk K, Orzeł A, Frączek M, Zatoński T (2021). Comparison of the clinical differences between COVID-19, SARS, influenza, and the common cold: a systematic literature review. *Advances in Clinical and Experimental Medicine*, *30*(1), 109–114. https://doi.org/10.17219/acem/129573
- Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, et al. (2022). Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. *The Lancet*, *399*(10335), 1618–1624. https://doi.org/10.1016/S0140-6736(22)00327-0
- Vashi B, Pettrone K, Wilson CS, Chenoweth JG, Brandsma J, Gregory MK, et al. (2025). COVID-19 symptom severity and duration among outpatients, July 2021-May 2023: the PROTECT observational study. *PLoS One*, *20*(2), e0314518. https://doi.org/10.1371/journal.pone.0314518
- Vihta KD, Pouwels KB, Peto TE, Pritchard E, House T, Studley R, et al. (2022). Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom. *Clinical Infectious Diseases*, *76*(3), e133–e141. https://doi.org/10.1093/cid/ciac613
- Sumner MW, Xie J, Zemek R, Winston K, Freire G, Burstein B, et al. (2023). Comparison of symptoms associated with SARS-CoV-2 variants among children in Canada. *JAMA Network Open*, *6*(3), e232328. https://doi.org/10.1001/jamanetworkopen.2023.2328
- Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. (2020). Factors associated with COVID-19-related death using OpenSAFELY. *Nature*, *584*(7821), 430–436. https://doi.org/10.1038/s41586-020-2521-4
- Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. (2022). Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. *New England Journal of Medicine*, *386*(15), 1397–1408. https://doi.org/10.1056/NEJMoa2118542
- Hou Y, Gu T, Ni Z, Shi X, Ranney ML, Mukherjee B (2025). Global prevalence of long COVID, its subtypes, and risk factors: an updated systematic review and meta-analysis. *Open Forum Infectious Diseases*, *12*(9), ofaf533. https://doi.org/10.1093/ofid/ofaf533
- Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B (2022). Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. *The Journal of Infectious Diseases*, *226*(9), 1593–1607. https://doi.org/10.1093/infdis/jiac136
- Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, Wade RG (2020). The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. *PLoS One*, *15*(6), e0234765. https://doi.org/10.1371/journal.pone.0234765
- Han Y, Guo J, Li X, Zhong Z (2025). Differences in clinical characteristics between coronavirus disease 2019 (COVID-19) and influenza: a systematic review and meta-analysis. *NPJ Primary Care Respiratory Medicine*, *35*(1), 8. https://doi.org/10.1038/s41533-025-00414-0


















